XGen Pharmaceuticals DJB
Michael Wakefield has over 30 years of work experience. Michael is currently working as the Vice President of Operations at XGen Pharmaceuticals DJB since September 2020. Prior to that, they worked at Mylan as the Senior Director for NA Commercial Sourcing from February 2017 to September 2020, and as the Director for Global API Sourcing - Injectables from November 2013 to January 2017. Before joining Mylan, they worked at Hospira as the Senior Sourcing Manager for Active Pharmaceutical Ingredients from January 2012 to November 2013, and as the Supply Chain Manager from June 2007 to May 2012. Michael also worked at Hospira in the past, from 2005 to 2007, as part of the Operations Planning team. Before joining Hospira, they worked at Abbott where they held multiple roles including Supervisor for Aseptic Parenteral Pharmaceutical Manufacturing from 2002 to 2005, Fermentation Development Process Support Bulk for Bulk API Manufacturing from 2000 to 2002, and Quality Assurance Analyst from 1998 to 2000. Michael started their career in the United States Air Force as an Electronic Warfare Specialist from 1988 to 1992.
Michael Wakefield studied Biology/Chemistry at Old Dominion University and completed their Bachelor of Science degree in 1997.
This person is not in any offices
XGen Pharmaceuticals DJB
Approaching the end of a 20 year career at a major pharmaceutical company, Dan Badia made a discovery. Where larger companies found obsolescence in small markets or low-profit yielding drugs, Dan saw reliable solutions proven to be effective and affordable alternatives for healthcare. With his wife, Shirley Harmening, Dan founded a company in 1973 on a bridge table in his bedroom. In just 14 years, this company would outgrow its birthplace and find a home in lower upstate New York. That growth would be sustained by introducing injectables into an established product line, mainly consisting of anti-infective, compounding powders. In 2003, that company would become X-GEN Pharmaceuticals, Inc. Affirming Dan’s original vision while embracing a dynamic industry, family-owned X-GEN Pharmaceuticals, Inc. remained a leader in generic, anti-infective pharmaceuticals. In this our 50th year in affiliation, we honor this heritage by carrying our founder’s initials in our new name, XGen Pharmaceuticals DJB. With reverence for the past and a passion for the future, we expect big results, driven by bold solutions and delivered by real people.